This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Garvan Institute of Medical Research. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Glenn Francis: Innovator in Breast Cancer Diagnosis
Introduction
Glenn Francis is a notable inventor based in Queensland, Australia. He has made significant contributions to the field of medical research, particularly in the diagnosis and monitoring of breast cancer. His innovative work has the potential to impact the lives of many individuals affected by this disease.
Latest Patents
Glenn Francis holds a patent titled "Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor." This patent provides methods and reagents for diagnosing, prognosing, and monitoring various subtypes of breast cancer, including estrogen receptor (ER) negative breast cancer, ER positive breast cancer, and triple negative breast cancer (TNBC). His work in this area is crucial for advancing breast cancer treatment and management.
Career Highlights
Glenn is affiliated with the Garvan Institute of Medical Research, where he continues to contribute to groundbreaking research. His dedication to improving breast cancer diagnostics showcases his commitment to medical innovation and patient care.
Collaborations
Some of his notable coworkers include Clare Stirzaker and Susan Joy Clark. Their collaborative efforts enhance the research environment and foster innovation in the field of medical science.
Conclusion
Glenn Francis is a pioneering inventor whose work in breast cancer diagnosis is making a significant difference in the medical field. His contributions are vital for improving patient outcomes and advancing cancer research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
